Johanna C.G.M. Buning-Kager

Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments

Catharina M. Korse, Babs G. Taal, Andrew Vincent et al. · European Journal of Cancer · 2011 · 119 citations · Full text

Tumor Biology, Neuro-oncology, Tumor Innervation +13

Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites

Gerard J. J. van Doornum, Catharina M. Korse, Johanna C.G.M. Buning-Kager et al. · British Journal of Cancer · 2003 · 60 citations · Full text

Ligands of Epidermal Growth Factor Receptor and the Insulin-Like Growth Factor Family as Serum Biomarkers for Response to Epidermal Growth Factor Receptor Inhibitors in Patients with Advanced Non-small Cell Lung Cancer

Marieke A. Vollebergh, Ingrid Kappers, Houke M. Klomp et al. · Journal of Thoracic Oncology · 2010 · 27 citations · Full text

Medicine, Pathology, Bronchial Neoplasm +6

A serum and platelet-rich plasma serotonin assay using liquid chromatography tandem mass spectrometry for monitoring of neuroendocrine tumor patients

Catharina M. Korse, Johanna C.G.M. Buning-Kager, Theodora C. Linders et al. · Clinica Chimica Acta · 2017 · 23 citations

Neuro-oncology, Neuroendocrine Tumor Patients, Endocrine Oncology +8